The company seeks to develop new drugs and guide them through various regulatory and development pathways in preparation for eventual commercialization.  The company focuses drug development efforts around disorders of the nervous system, such as chronic pain. Pain Therapeutics has not received regulatory approval for any of its therapeutic candidates.